Enzymatica AB (publ) (STO:ENZY)
2.120
+0.090 (4.43%)
Oct 10, 2025, 5:29 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 514.60 million as of October 10, 2025. Its market cap has increased by 34.91% in one year.
Market Cap
514.60M
Enterprise Value
470.90M
Revenue
50.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.12
Market Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 514.60M, an increase of 372.42%. That is a compound annual growth rate of 11.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 514.60M | 50.95% |
Dec 30, 2024 | 340.92M | -47.39% |
Dec 29, 2023 | 647.99M | -12.33% |
Dec 30, 2022 | 739.16M | -43.36% |
Dec 30, 2021 | 1.31B | -51.13% |
Dec 30, 2020 | 2.67B | 371.03% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 105.55B |
Sectra AB | 58.76B |
Getinge AB | 57.22B |
Camurus AB | 41.49B |
Medicover AB | 39.71B |
Asker Healthcare Group AB | 33.44B |
BioArctic AB | 26.56B |
AddLife AB | 22.67B |